samedan logo

home > news > detailed info

A&M Cold Storage Rallies to Help Global COVID-19 Vaccine Distribution Efforts via Carrier Pods Unit Availability and Expanded Lynx Capabilities

A&M Cold Storage

– A&M Cold Storage recently responded to Carrier’s call to support global COVID-19 vaccine distribution efforts by making immediately available 90 Carrier Pods™ monitored by Sensitech® for deployment to help address the anticipated increase in demand for refrigerated storage capacity. Carrier and Sensitech are part of Carrier Global Corporation (NYSE: CARR), a leading global provider of healthy, safe and sustainable building and cold chain solutions.

“We are happy to support this important mission, as we believe that tackling the pandemic is an essential imperative which requires all aspects of the cold chain to come together to ensure the safe storage and movement of COVID-19 vaccines,” said Jeff Quellhorst, director of sales, A&M Cold Storage. “These Carrier Pods not only help ensure end-to-end cold chain visibility and integrity but are also uniquely suited to cater to the rigorous on-ground requirements of vaccine distribution.”

Each of these 90 Carrier Pods is fitted with Carrier’s TripLINK™ data management platform, which provides 24/7 remote and secure monitoring of the health of the refrigerated container and cargo, with an integration with the Lynx™ digital platform. These units have been adapted for optimal use in the field with flat flooring, interior lights and doors with safety releases and easy access that do not downgrade the insulation or cooling capabilities of the container, helping to ensure the shelf life of the temperature-sensitive COVID-19 vaccines.

“A&M Cold Storage has risen to the occasion by making 90 Carrier Pod units immediately available which could be highly beneficial to pharmaceutical companies, distribution centers and vaccine administrators,” said Christopher Kranick, associate sales director, The Americas, Global Container Refrigeration, Carrier.

With Carrier Pods monitored by Sensitech, container refrigeration units can deliver temperature control within +/- 0.25 degrees Celsius and temperatures down to 40 degrees Celsius, while their monitoring devices can track temperatures down to dry ice conditions of -95 degrees Celsius. Their mobility allows for easy relocation to address shifting capacity demands or temporary vaccine administration locations.

Carrier Pods monitored by Sensitech are one of the solutions offered through Carrier’s Healthy, Safe, Sustainable Cold Chain Program to preserve and protect the supply of food, medicine and vaccines.
phone 855-226-3685
email 1176 Suwanee, GA 30024
Print this page
Send to a friend
News and Press Releases

Bachem is now expanding into Oligonucleotides

The global market for oligonucleotide therapeutics is expanding rapidly. What is Bachem’s strategy in entering this competitive environment? Dr. Torsten Wöhr*: I think it is important for our customers to understand that the decision by Bachem leadership to enter the field of oligonucleotide manufacturing was well-prepared and ultimately taken in line with the company’s long-term growth plan. We are operative since 2019 and are gradually expanding our expert resource pool, capabilities and capacity for oligonucleotides.
More info >>

White Papers

Customising the Cold Chain

World Courier

Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
More info >>

Industry Events

DIA Europe 2021

15-19 March 2021, VIRTUAL CONFERENCE

DIA Europe is the must-attend event for all life science professionals working in drug development, from discovery to marketed use. It encourages open collaboration by bringing together representatives from the entire spectrum of the life science landscape and facilitating crucial discussions across several topic tracks: Clinical Development, Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy, and many more.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement